These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 33155867)

  • 1. Technical and biological review of authorized medical devices for platelets-rich plasma preparation in the field of regenerative medicine.
    Magalon J; Brandin T; Francois P; Degioanni C; De Maria L; Grimaud F; Veran J; Dignat-George F; Sabatier F
    Platelets; 2021 Feb; 32(2):200-208. PubMed ID: 33155867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization and comparison of 5 platelet-rich plasma preparations in a single-donor model.
    Magalon J; Bausset O; Serratrice N; Giraudo L; Aboudou H; Veran J; Magalon G; Dignat-Georges F; Sabatier F
    Arthroscopy; 2014 May; 30(5):629-38. PubMed ID: 24725317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DEPA classification: a proposal for standardising PRP use and a retrospective application of available devices.
    Magalon J; Chateau AL; Bertrand B; Louis ML; Silvestre A; Giraudo L; Veran J; Sabatier F
    BMJ Open Sport Exerc Med; 2016; 2(1):e000060. PubMed ID: 27900152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the applications of platelet-rich plasma in tissue engineering and regenerative medicine: evidence from goat and sheep experimental research.
    Sharun K; Banu SA; El-Husseiny HM; Abualigah L; Pawde AM; Dhama K; Amarpal
    Connect Tissue Res; 2024 Sep; 65(5):364-382. PubMed ID: 39246090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-rich plasma and its derivatives as promising bioactive materials for regenerative medicine: basic principles and concepts underlying recent advances.
    Kawase T
    Odontology; 2015 May; 103(2):126-35. PubMed ID: 26040505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution, recovery and concentration of platelets and leukocytes in L-PRP prepared by centrifugation.
    de Melo BAG; Martins Shimojo AA; Marcelino Perez AG; Duarte Lana JFS; Andrade Santana MH
    Colloids Surf B Biointerfaces; 2018 Jan; 161():288-295. PubMed ID: 29096373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the Different Preparation Methods to Obtain Autologous Non-Activated Platelet-Rich Plasma (A-PRP) and Activated Platelet-Rich Plasma (AA-PRP) in Plastic Surgery: Wound Healing and Hair Regrowth Evaluation.
    Gentile P; Calabrese C; De Angelis B; Dionisi L; Pizzicannella J; Kothari A; De Fazio D; Garcovich S
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet rich plasma in xeno-free stem cell culture: the impact of platelet count and processing method.
    Pawitan JA
    Curr Stem Cell Res Ther; 2012 Sep; 7(5):329-35. PubMed ID: 22849700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic Review-The Potential Implications of Different Platelet-Rich Plasma (PRP) Concentrations in Regenerative Medicine for Tissue Repair.
    Gentile P; Garcovich S
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32784862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concentrations of Blood Components in Commercial Platelet-Rich Plasma Separation Systems: A Review of the Literature.
    Oudelaar BW; Peerbooms JC; Huis In 't Veld R; Vochteloo AJH
    Am J Sports Med; 2019 Feb; 47(2):479-487. PubMed ID: 29337592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous Platelet-Rich Plasma Efficacy in the Field of Regenerative Medicine: Product and Quality Control.
    Popescu MN; Iliescu MG; Beiu C; Popa LG; Mihai MM; Berteanu M; Ionescu AM
    Biomed Res Int; 2021; 2021():4672959. PubMed ID: 34368346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in Platelet Rich Plasma-Derived Extracellular Vesicles for Regenerative Medicine: A Systematic-Narrative Review.
    Anitua E; Troya M; Falcon-Pérez JM; López-Sarrio S; González E; Alkhraisat MH
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A retrospective analysis of a commercially available platelet-rich plasma kit during clinical use.
    Prysak MH; Kyriakides CP; Zukofsky TA; Reutter SE; Cheng J; Lutz GE
    PM R; 2021 Dec; 13(12):1410-1417. PubMed ID: 33543595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood Plasma Derivatives for Tissue Engineering and Regenerative Medicine Therapies.
    Santos SCNDS; Sigurjonsson ÓE; Custódio CA; Mano JFCDL
    Tissue Eng Part B Rev; 2018 Dec; 24(6):454-462. PubMed ID: 29737237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Call for Standardization in Platelet-Rich Plasma Preparation Protocols and Composition Reporting: A Systematic Review of the Clinical Orthopaedic Literature.
    Chahla J; Cinque ME; Piuzzi NS; Mannava S; Geeslin AG; Murray IR; Dornan GJ; Muschler GF; LaPrade RF
    J Bone Joint Surg Am; 2017 Oct; 99(20):1769-1779. PubMed ID: 29040132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimisation of a double-centrifugation method for preparation of canine platelet-rich plasma.
    Shin HS; Woo HM; Kang BJ
    BMC Vet Res; 2017 Jun; 13(1):198. PubMed ID: 28651609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular Components and Growth Factor Content of Platelet-Rich Plasma With a Customizable Commercial System.
    Baria M; Vasileff WK; Miller M; Borchers J; Flanigan DC; Durgam SS
    Am J Sports Med; 2019 Apr; 47(5):1216-1222. PubMed ID: 30848659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contributions for classification of platelet rich plasma - proposal of a new classification: MARSPILL.
    Lana JFSD; Purita J; Paulus C; Huber SC; Rodrigues BL; Rodrigues AA; Santana MH; Madureira JL; Malheiros Luzo ÂC; Belangero WD; Annichino-Bizzacchi JM
    Regen Med; 2017 Jul; 12(5):565-574. PubMed ID: 28758836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biotherapeutic Applications of Platelet-Rich Plasma in Regenerative Medicine.
    Pineda-Cortel MR; Suarez C; Cabrera JT; Daya M; Bernardo-Bueno MM; Vergara RC; Villavieja A
    Tissue Eng Regen Med; 2023 Oct; 20(6):811-828. PubMed ID: 37651090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet-rich plasma (PRP) and Platelet-Rich Fibrin (PRF): surgical adjuvants, preparations for in situ regenerative medicine and tools for tissue engineering.
    Bielecki T; Dohan Ehrenfest DM
    Curr Pharm Biotechnol; 2012 Jun; 13(7):1121-30. PubMed ID: 21740380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.